Cite
MLA Citation
A B Lassman et al.. “OS10.6 Infigratinib (BGJ398) in patients with recurrent gliomas with fibroblast growth factor receptor (FGFR) alterations: a multicenter phase II study.” Neuro-oncology, vol. 21, n.d., pp. iii21–iii22. http://access.bl.uk/ark:/81055/vdc_100126060972.0x00000f